Telix Pharmaceuticals (ASX:TLX)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health Check: Investors catch a falling knife as biotech big names bounce from lows
Health Check: Dimerix shares soar as the company hooks the billion-dollar big one in the US
Health Check: Telix licks its wounds after FDA knocks back brain cancer diagnostic
Lunch Wrap: ASX rallies as China teases stimulus; Telix hit by FDA blow
Scott Power: ASX health stocks up in strong start to reporting season
Rise and Shine: Everything you need to know before the ASX opens
Closing Bell: ASX rallies as Trump softens up on tariffs; Capricorn CEO faces charge
Health Check: Telix shares rocket after bullish quarterly sales update
Lunch Wrap: ASX lights up as risk returns; Paladin rockets 25pc but gold sees heavy profit-taking
Health Check: Drug sector panic sets in at the prospect of a Trump tariff ‘pharma-geddon’
Health Check: Relax! Tariffs shape as the next Y2K as biotechs report ‘nothing to see here’
Health Check: Liberation Day spares the global drug sector – for now
Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much
